-
公开(公告)号:DE3869163D1
公开(公告)日:1992-04-23
申请号:DE3869163
申请日:1988-03-09
Applicant: HOFFMANN LA ROCHE
Inventor: KLOETZER WILHELM PROF DR , MONTAVON MARC DR , MUESSNER RENATE DR , SINGEWALD NICOLAS
IPC: C07D233/56 , A61K31/415 , A61K31/4164 , A61K31/417 , A61P3/00 , A61P29/00 , C07D233/61 , C07D233/64 , C07D233/80 , C07D233/84 , C07D233/88 , C07D521/00
Abstract: Imidazole derivatives of the formula I wherein R1 and R2 each is lower alkyl, X is a residue of the formula R3 is hydrogen and R4 is hydrogen or lower alkyl or R3 and R4 taken together are an additional carbon-nitrogen bond; R5 is hydrogen or lower alkyl; R6 is hydrogen, lower alkyl, lower alkylthio or a residue of the formula -NR7R8; and R7 and R8 each is lower alkyl or taken together with the nitrogen atom are a 5- or 6-membered saturated heterocycle; and pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I possess valuable pharmacodynamic properties, especially inflammation-inhibiting and edema-inhibiting properties, so that they can be used for the control or prevention of illnesses, especially for the control or prevention of inflammations and edemas.
-
2.
公开(公告)号:HUT49581A
公开(公告)日:1989-10-30
申请号:HU123888
申请日:1988-03-16
Applicant: HOFFMANN LA ROCHE
Inventor: KLOETZER WILHELM , MONTAVON MARC , MUESSNER RENATE , SINGEWALD NICOLAS
IPC: A61K31/415 , A61K31/4164 , A61K31/417 , A61P3/00 , A61P29/00 , C07D233/56 , C07D233/61 , C07D233/64 , C07D233/80 , C07D233/84 , C07D233/88 , C07D521/00 , C07D413/04
Abstract: Imidazole derivatives of the formula I wherein R1 and R2 each is lower alkyl, X is a residue of the formula R3 is hydrogen and R4 is hydrogen or lower alkyl or R3 and R4 taken together are an additional carbon-nitrogen bond; R5 is hydrogen or lower alkyl; R6 is hydrogen, lower alkyl, lower alkylthio or a residue of the formula -NR7R8; and R7 and R8 each is lower alkyl or taken together with the nitrogen atom are a 5- or 6-membered saturated heterocycle; and pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I possess valuable pharmacodynamic properties, especially inflammation-inhibiting and edema-inhibiting properties, so that they can be used for the control or prevention of illnesses, especially for the control or prevention of inflammations and edemas.
-
公开(公告)号:AU613349B2
公开(公告)日:1991-08-01
申请号:AU1353288
申请日:1988-03-21
Applicant: HOFFMANN LA ROCHE
Inventor: KLOTZER WILHELM , MONTAVON MARC , MUSSNER RENATE , SINGEWALD NICOLAS
IPC: C07D233/56 , A61K31/415 , A61K31/4164 , A61K31/417 , A61P3/00 , A61P29/00 , C07D233/61 , C07D233/64 , C07D233/80 , C07D233/84 , C07D233/88 , C07D521/00
Abstract: Imidazole derivatives of the formula I wherein R1 and R2 each is lower alkyl, X is a residue of the formula R3 is hydrogen and R4 is hydrogen or lower alkyl or R3 and R4 taken together are an additional carbon-nitrogen bond; R5 is hydrogen or lower alkyl; R6 is hydrogen, lower alkyl, lower alkylthio or a residue of the formula -NR7R8; and R7 and R8 each is lower alkyl or taken together with the nitrogen atom are a 5- or 6-membered saturated heterocycle; and pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I possess valuable pharmacodynamic properties, especially inflammation-inhibiting and edema-inhibiting properties, so that they can be used for the control or prevention of illnesses, especially for the control or prevention of inflammations and edemas.
-
公开(公告)号:AU1353288A
公开(公告)日:1988-09-22
申请号:AU1353288
申请日:1988-03-21
Applicant: HOFFMANN LA ROCHE
Inventor: KLOTZER WILHELM , MONTAVON MARC , MUSSNER RENATE , SINGEWALD NICOLAS
IPC: C07D233/56 , A61K31/415 , A61K31/4164 , A61K31/417 , A61P3/00 , A61P29/00 , C07D233/61 , C07D233/64 , C07D233/80 , C07D233/84 , C07D233/88 , C07D521/00
Abstract: Imidazole derivatives of the formula I wherein R1 and R2 each is lower alkyl, X is a residue of the formula R3 is hydrogen and R4 is hydrogen or lower alkyl or R3 and R4 taken together are an additional carbon-nitrogen bond; R5 is hydrogen or lower alkyl; R6 is hydrogen, lower alkyl, lower alkylthio or a residue of the formula -NR7R8; and R7 and R8 each is lower alkyl or taken together with the nitrogen atom are a 5- or 6-membered saturated heterocycle; and pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I possess valuable pharmacodynamic properties, especially inflammation-inhibiting and edema-inhibiting properties, so that they can be used for the control or prevention of illnesses, especially for the control or prevention of inflammations and edemas.
-
公开(公告)号:NO881199A
公开(公告)日:1988-09-21
申请号:NO881199
申请日:1988-03-18
Applicant: HOFFMANN LA ROCHE
Inventor: KLOETZER WILHELM , MONTAVON MARC , MUESSNER RENATE , SINGEWALD NICOLAS
IPC: C07D233/56 , A61K31/415 , A61K31/4164 , A61K31/417 , A61P3/00 , A61P29/00 , C07D233/80 , C07D233/84 , C07D233/88 , C07D521/00 , C07D233/64 , C07D413/04
CPC classification number: C07D231/12 , C07D233/56 , C07D233/84 , C07D233/88 , C07D249/08
-
公开(公告)号:NO881199D0
公开(公告)日:1988-03-18
申请号:NO881199
申请日:1988-03-18
Applicant: HOFFMANN LA ROCHE
Inventor: KLOETZER WILHELM , MONTAVON MARC , MUESSNER RENATE , SINGEWALD NICOLAS
IPC: A61K31/415 , C07D233/56 , A61K31/4164 , A61K31/417 , A61P3/00 , A61P29/00 , C07D233/61 , C07D233/64 , C07D233/80 , C07D233/84 , C07D233/88 , C07D521/00 , C07D233/00
Abstract: Imidazole derivatives of the formula I wherein R1 and R2 each is lower alkyl, X is a residue of the formula R3 is hydrogen and R4 is hydrogen or lower alkyl or R3 and R4 taken together are an additional carbon-nitrogen bond; R5 is hydrogen or lower alkyl; R6 is hydrogen, lower alkyl, lower alkylthio or a residue of the formula -NR7R8; and R7 and R8 each is lower alkyl or taken together with the nitrogen atom are a 5- or 6-membered saturated heterocycle; and pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I possess valuable pharmacodynamic properties, especially inflammation-inhibiting and edema-inhibiting properties, so that they can be used for the control or prevention of illnesses, especially for the control or prevention of inflammations and edemas.
-
公开(公告)号:NO170215C
公开(公告)日:1992-09-23
申请号:NO881199
申请日:1988-03-18
Applicant: HOFFMANN LA ROCHE
Inventor: KLOETZER WILHELM , MONTAVON MARC , MUESSNER RENATE , SINGEWALD NICOLAS
IPC: A61K31/415 , A61K31/4164 , C07D233/56 , A61K31/417 , A61P3/00 , A61P29/00 , C07D233/61 , C07D233/64 , C07D233/80 , C07D233/84 , C07D233/88 , C07D521/00 , C07D413/04
Abstract: Imidazole derivatives of the formula I wherein R1 and R2 each is lower alkyl, X is a residue of the formula R3 is hydrogen and R4 is hydrogen or lower alkyl or R3 and R4 taken together are an additional carbon-nitrogen bond; R5 is hydrogen or lower alkyl; R6 is hydrogen, lower alkyl, lower alkylthio or a residue of the formula -NR7R8; and R7 and R8 each is lower alkyl or taken together with the nitrogen atom are a 5- or 6-membered saturated heterocycle; and pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I possess valuable pharmacodynamic properties, especially inflammation-inhibiting and edema-inhibiting properties, so that they can be used for the control or prevention of illnesses, especially for the control or prevention of inflammations and edemas.
-
公开(公告)号:AT73777T
公开(公告)日:1992-04-15
申请号:AT88103746
申请日:1988-03-09
Applicant: HOFFMANN LA ROCHE
Inventor: KLOETZER WILHELM PROF DR , MONTAVON MARC DR , MUESSNER RENATE DR , SINGEWALD NICOLAS
IPC: C07D233/56 , A61K31/415 , A61K31/4164 , A61K31/417 , A61P3/00 , A61P29/00 , C07D233/61 , C07D233/64 , C07D233/80 , C07D233/84 , C07D233/88 , C07D521/00
-
公开(公告)号:CS8800891A2
公开(公告)日:1990-09-12
申请号:CS89188
申请日:1988-02-12
Applicant: HOFFMANN LA ROCHE
Inventor: KLOTZER WILHELM , MONTAVON MARC , MUSSNER RENATE , SINGEWALD NICOLAS
IPC: C07D233/56 , A61K31/415 , A61K31/4164 , A61K31/417 , A61P3/00 , A61P29/00 , C07D233/61 , C07D233/64 , C07D233/80 , C07D233/84 , C07D233/88 , C07D521/00
Abstract: Imidazole derivatives of the formula I wherein R1 and R2 each is lower alkyl, X is a residue of the formula R3 is hydrogen and R4 is hydrogen or lower alkyl or R3 and R4 taken together are an additional carbon-nitrogen bond; R5 is hydrogen or lower alkyl; R6 is hydrogen, lower alkyl, lower alkylthio or a residue of the formula -NR7R8; and R7 and R8 each is lower alkyl or taken together with the nitrogen atom are a 5- or 6-membered saturated heterocycle; and pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I possess valuable pharmacodynamic properties, especially inflammation-inhibiting and edema-inhibiting properties, so that they can be used for the control or prevention of illnesses, especially for the control or prevention of inflammations and edemas.
-
公开(公告)号:PT87025A
公开(公告)日:1988-04-01
申请号:PT8702588
申请日:1988-03-18
Applicant: HOFFMANN LA ROCHE
Inventor: KLOTZER WILHELM , MONTAVON MARC , MUSSNER RENATE , SINGEWALD NICOLAS
IPC: A61K31/415 , A61K31/4164 , C07D233/56 , A61K31/417 , A61P3/00 , A61P29/00 , C07D233/61 , C07D233/64 , C07D233/80 , C07D233/84 , C07D233/88 , C07D521/00 , C07D233/54 , A61K31/41
Abstract: Imidazole derivatives of the formula I wherein R1 and R2 each is lower alkyl, X is a residue of the formula R3 is hydrogen and R4 is hydrogen or lower alkyl or R3 and R4 taken together are an additional carbon-nitrogen bond; R5 is hydrogen or lower alkyl; R6 is hydrogen, lower alkyl, lower alkylthio or a residue of the formula -NR7R8; and R7 and R8 each is lower alkyl or taken together with the nitrogen atom are a 5- or 6-membered saturated heterocycle; and pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I possess valuable pharmacodynamic properties, especially inflammation-inhibiting and edema-inhibiting properties, so that they can be used for the control or prevention of illnesses, especially for the control or prevention of inflammations and edemas.
-
-
-
-
-
-
-
-
-